Literature DB >> 27541597

Transcriptional regulation of the IL-7Rα gene by dexamethasone and IL-7 in primary human CD8 T cells.

Juzer A Kakal1,2, Feras M Ghazawi1, Elliott M Faller1, Scott M Sugden1,2, Parmvir Parmar1, Paul A MacPherson3,4,5.   

Abstract

Interleukin-7 is essential for the development and maintenance of T cells, and the expression of the IL-7 receptor is tightly regulated at every stage of the T cell's lifespan. In mature CD8 T cells, IL-7 plays important roles in cell survival, peripheral homeostasis, and cytolytic function. The IL-7 receptor alpha-chain (CD127) is expressed at high levels on naïve and memory cells, but it is rapidly downregulated upon IL-7 stimulation. In this study, we illustrate the dynamicity of the CD127 promoter and show that it possesses positive as well as negative regulatory sites involved in upregulating and downregulating CD127 expression, respectively. We cloned the CD127 gene promoter and identified key cis-regulatory elements required for CD127 expression in mature resting primary CD8 T cells. The core promoter necessary for efficient basal transcription is contained within the first 262 bp upstream of the TATA box. Additional positive regulatory elements are located between -1200 and -2406 bp, conferring a further 2- to 4-fold enhancement in gene expression. While transcription of the CD127 gene is increased directly through a glucocorticoid response element located between -2255 and -2269 bp upstream of the TATA box, we identified a suppressive region that lies upstream of 1760 bp from the TATA box, which is likely involved in the IL-7-mediated suppression of CD127 transcription. Finally, we illustrated IL-7 does not bias alternative splicing of CD127 transcripts in primary human CD8 T cells.

Entities:  

Keywords:  CD127; CD127 promoter; Cytotoxic T-lymphocytes; Interleukin-7; Interleukin-7 receptor

Mesh:

Substances:

Year:  2016        PMID: 27541597     DOI: 10.1007/s00251-016-0948-4

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  55 in total

1.  Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function.

Authors:  Denise Pargmann; Raif Yücel; Christian Kosan; Ingrid Saba; Ludger Klein-Hitpass; Simone Schimmer; Florian Heyd; Ulf Dittmer; Tarik Möröy
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

2.  Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling.

Authors:  Bing Tian; David E Nowak; Mohammad Jamaluddin; Shaofei Wang; Allan R Brasier
Journal:  J Biol Chem       Date:  2005-02-18       Impact factor: 5.157

3.  Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

Authors:  Mirko Paiardini; Barbara Cervasi; Helmut Albrecht; Alagarraju Muthukumar; Richard Dunham; Shari Gordon; Henry Radziewicz; Giuseppe Piedimonte; Mauro Magnani; Maria Montroni; Susan M Kaech; Amy Weintrob; John D Altman; Donald L Sodora; Mark B Feinberg; Guido Silvestri
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

4.  Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.

Authors:  A Korte; J Köchling; L Badiali; C Eckert; J Andreae; W Geilen; C Kebelmann-Betzing; T Taube; S Wu; G Henze; K Seeger
Journal:  Cytokine       Date:  2000-11       Impact factor: 3.861

5.  Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients.

Authors:  Bence Rethi; Caroline Fluur; Ann Atlas; Malgorzata Krzyzowska; Frida Mowafi; Sven Grützmeier; Angelo De Milito; Rino Bellocco; Kerstin I Falk; Eva Rajnavölgyi; Francesca Chiodi
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

6.  Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment.

Authors:  Loretta L Doan; Mary Kate Kitay; Qing Yu; Alfred Singer; Sabine Herblot; Trang Hoang; Susan E Bear; Herbert C Morse; Philip N Tsichlis; H Leighton Grimes
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

7.  Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression.

Authors:  T Hernández-Caselles; M Martínez-Esparza; D Sancho; G Rubio; P Aparicio
Journal:  Hum Immunol       Date:  1995-07       Impact factor: 2.850

8.  Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.

Authors:  F Mercier; M-R Boulassel; B Yassine-Diab; C Tremblay; N-F Bernard; R-P Sekaly; J-P Routy
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

9.  Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals.

Authors:  C Carini; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  1994-02       Impact factor: 2.205

10.  Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling.

Authors:  Nuno L Alves; Ester M M van Leeuwen; Ingrid A M Derks; René A W van Lier
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

View more
  2 in total

1.  Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.

Authors:  Lauren K Meyer; Benjamin J Huang; Cristina Delgado-Martin; Ritu P Roy; Aaron Hechmer; Anica M Wandler; Tiffaney L Vincent; Paolo Fortina; Adam B Olshen; Brent L Wood; Terzah M Horton; Kevin M Shannon; David T Teachey; Michelle L Hermiston
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

2.  HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.

Authors:  Jama Dalel; Seng K Ung; Peter Hayes; S Lucas Black; Sarah Joseph; Deborah F King; Julia Makinde; Jill Gilmour
Journal:  AIDS       Date:  2021-07-01       Impact factor: 4.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.